American International Group Inc. raised its position in Clorox Co (NYSE:CLX) by 2.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 143,890 shares of the company’s stock after purchasing an additional 3,277 shares during the period. American International Group Inc.’s holdings in Clorox were worth $19,461,000 as of its most recent filing with the SEC.

A number of other large investors have also recently modified their holdings of CLX. Cornerstone Wealth Management LLC bought a new stake in shares of Clorox during the second quarter worth $105,000. Centaurus Financial Inc. bought a new stake in shares of Clorox during the first quarter worth $106,000. Ostrum Asset Management bought a new stake in shares of Clorox during the first quarter worth $112,000. Whittier Trust Co. of Nevada Inc. increased its position in shares of Clorox by 1,297.4% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 1,621 shares of the company’s stock worth $148,000 after acquiring an additional 1,505 shares in the last quarter. Finally, IMS Capital Management bought a new stake in shares of Clorox during the second quarter worth $161,000. 76.12% of the stock is owned by hedge funds and other institutional investors.

In related news, SVP Michael R. Costello sold 9,265 shares of the stock in a transaction on Monday, August 13th. The shares were sold at an average price of $140.02, for a total transaction of $1,297,285.30. Following the completion of the transaction, the senior vice president now owns 34,293 shares in the company, valued at $4,801,705.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.00% of the company’s stock.

CLX has been the subject of several research reports. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Tuesday, May 8th. Goldman Sachs Group downgraded shares of Clorox from a “neutral” rating to a “sell” rating and lowered their price objective for the stock from $127.00 to $112.00 in a research report on Tuesday, July 17th. They noted that the move was a valuation call. ValuEngine downgraded shares of Clorox from a “hold” rating to a “sell” rating in a research report on Saturday, April 21st. Bank of America increased their price objective on shares of Clorox from $130.00 to $140.00 and gave the stock a “neutral” rating in a research report on Monday, July 16th. Finally, Citigroup lowered their price objective on shares of Clorox from $139.00 to $126.00 and set a “neutral” rating for the company in a research report on Friday, May 4th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the company’s stock. Clorox currently has a consensus rating of “Hold” and a consensus target price of $130.42.

Shares of CLX opened at $147.53 on Friday. Clorox Co has a 12 month low of $113.57 and a 12 month high of $150.40. The firm has a market cap of $18.16 billion, a P/E ratio of 23.57, a price-to-earnings-growth ratio of 2.90 and a beta of 0.36. The company has a quick ratio of 0.67, a current ratio of 1.09 and a debt-to-equity ratio of 3.15.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, August 2nd. The company reported $1.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.58 by $0.08. Clorox had a net margin of 13.44% and a return on equity of 103.18%. The business had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.72 billion. During the same quarter in the prior year, the company posted $1.53 earnings per share. The firm’s revenue was up 2.7% on a year-over-year basis. equities research analysts predict that Clorox Co will post 6.41 EPS for the current year.

Clorox declared that its Board of Directors has approved a stock buyback program on Thursday, May 24th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to reacquire up to 12.6% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its stock is undervalued.

The firm also recently announced a quarterly dividend, which was paid on Friday, August 17th. Investors of record on Wednesday, August 1st were issued a dividend of $0.96 per share. This represents a $3.84 annualized dividend and a yield of 2.60%. The ex-dividend date was Tuesday, July 31st. Clorox’s payout ratio is 61.34%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.

See Also: Diversification in Your Portfolio

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.